A Trial Investigating the Absorption, Metabolism and Excretion of Somapacitan After Single Dosing in Healthy Male Subjects
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to investigate the absorption,
metabolism and excretion of somapacitan after single subcutaneous dosing in healthy male
subjects.